Chronic Kidney Disease, Experimental Models, Biomarkers, Precision Medicine 3

15 Apr 2024 5:45 p.m. 6:45 p.m.

MON-073 to MON-088

Ahmed Akl Poster Moderator

Time	Session

5:45 p.m. 6:45 p.m.	KIDNEY ELASTOMETRY AND X-FLOW ALGORITHMS: NEW METHODS TO INTERROGATE THE PROTEINURIA AND EFFECTS OF EMPAGLIFLOZIN WCN24-AB-1365, Poster Board= MON-073 MON-073 Pietro Iulianiello Poster Presenter	A PROSPECTIVE STUDY TO ANALYSE THE ACCURACY OF ESTIMATED GFR EQUATIONS AS COMPARED TO MEASURED GFR BY IOHEXOL CLEARANCE IN PATIENTS WITH LIVER CIRRHOSIS. WCN24-AB-1597, Poster Board= MON-074 MON-074 Madhuri Kashyap Poster Presenter	TO DETERMINE THE EFFICACY OF LACTOFERRIN IN IMPROVING HEMOGLOBIN LEVELS IN CHRONIC KIDNEY DISEASE PATIENTS WITH IRON DEFICIENCY ANEMIA WCN24-AB-1323, Poster Board= MON-075 MON-075 Madhuri Kashyap Poster Presenter	THE EFFECT OF LACTOFERRIN ON HEMOGLOBIN, ERYTHROFERRONE AND HEPCIDIN LEVELS IN CHRONIC KIDNEY DISEASE WCN24-AB-1274, Poster Board= MON-076 MON-076 Madhuri Kashyap Poster Presenter	INHIBITION OF ANGIOPOIETIN-2 COMBINED WITH A HIGH LEVEL OF ANGIOTENSIN-II EXACERBATES RENAL FIBROSIS WCN24-AB-782, Poster Board= MON-077 MON-077 An Jie Luo Poster Presenter	NOVEL BIOMARKERS AND PREDICTION OF KIDNEY DISEASE PROGRESSION IN AUSTRALIAN FIRST NATION PEOPLE WITH AND WITHOUT DIABETES: THE eGFR STUDY WCN24-AB-1077, Poster Board= MON-078 MON-078 Richard Macisaac Poster Presenter	THE ROLE OF OXYSTEROL-BINDING PROTEIN LIKE 7 IN PODOCYTE HEALTH: IMPLICATIONS IN CHRONIC KIDNEY DISEASE PATHOPHYSIOLOGY WCN24-AB-1213, Poster Board= MON-079 MON-079 Jeffrey Pressly Poster Presenter	PIRFENIDONE DOWNREGULATES RENAL FIBROGENESIS AND INFLAMMATION SLOWING CKD PROGRESSION IN AN EXPERIMENTAL MODEL OF HYPERTENSIVE NEPHROSCLEROSIS WCN24-AB-1335, Poster Board= MON-080 MON-080 Ana Laura Rubio Francini Poster Presenter	EARLY PREDICTION OF FRAILTY, FUNCTIONAL IMPAIRMENT, AND MORTALITY WITH NON-INVASIVE BIOELECTRICAL IMPEDANCE ANALYSIS IN ECUADORIAN HEMODIALYSIS PATIENTS WCN24-AB-1818, Poster Board= MON-081 MON-081 Juan Cristóbal Santacruz Mancheno Poster Presenter	ASSESSMENT OF THE EFFECT OF HEPATIC IMPAIRMENT ON IPTACOPAN PHARMACOKINETICS WCN24-AB-748, Poster Board= MON-082 MON-082 Robert Schmouder Poster Presenter	PHARMACOKINETICS OF SINGLE DOSES OF IPTACOPAN WCN24-AB-555, Poster Board= MON-083 MON-083 Robert Schmouder Poster Presenter	SINGLE DOSE OF IPTACOPAN TREATMENT RAPIDLY DESCREASES PLASMA COMPLEMENT Bb LEVELS WCN24-AB-550, Poster Board= MON-084 MON-084 Robert Schmouder Poster Presenter	ASSESSMENT OF CORRELATION BETWEEN 24-HOUR URINARY SODIUM EXCRETION AND 24-HOUR AMBULATORY BLOOD PRESSURE IN HEALTHY SUBJECTS AND CHRONIC KIDNEY DISEASE PATIENTS WCN24-AB-231, Poster Board= MON-085 MON-085 John Abraham Tharayil Poster Presenter	THE EFFECTS OF HYPOXIA-INDUCIBLE FACTOR-2 INACTIVATION IN MURINE KIDNEY DISEASE MODELS WCN24-AB-796, Poster Board= MON-086 MON-086 Pei-Zhen Tsai Poster Presenter	SAFETY AND EFFICACY OF IPTACOPAN IN ADOLESCENT PATIENTS WITH IDIOPATHIC (PRIMARY) IMMUNE-COMPLEX-MEDIATED MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (IC-MPGN) WCN24-AB-1146, Poster Board= MON-087 MON-087 Nicholas Webb Poster Presenter	THE RISK FACTORS OF COVID-19 ADVERSE OUTCOME AND FOLLOW-UP TWO-YEAR SURVIVAL RATE IN PATIENTS ON MAINTENANCE HEMODIALYSIS WCN24-AB-837, Poster Board= MON-088 MON-088 Eugene Zeltyn-Abramov Poster Presenter